Listar Investigación y Desarrollo por autor "Castellani R.J."
Mostrando ítems 1-3 de 3
-
Article
Co-administration of TiO2 nanowired mesenchymal stem cells with cerebrolysin potentiates neprilysin level and reduces brain pathology in alzheimer’s disease (2020)
Sharma H.S.; Muresanu D.F.; Lafuente J.V.; Patnaik R.; Tian Z.R.; Ozkizilcik A.; Castellani R.J.; Mössler H.; Sharma A. (Humana Press Inc., 2018) -
Article
Histamine H3 inverse agonist BF 2649 or antagonist with partial h4 agonist activity clobenpropit reduces amyloid beta peptide-induced brain pathology in alzheimer’s disease (2020)
Patnaik R.; Sharma A.; Skaper S.D.; Muresanu D.F.; Lafuente J.V.; Castellani R.J.; Nozari A.; Sharma H.S. (Humana Press Inc., 2018) -
Conference Paper
Nanodelivery of cerebrolysin reduces depressive stress induced exacerbation of Alzheimer's disease brain pathology following amyloid-beta peptide infusion (2020)
Sharma H.S.; Muresanu D.F.; Lafuente J.V.; Patnaik R.; Tian Z.R.; Ozkizilcik A.; Castellani R.J.; Mossier H.; Sharma A. (TechConnect, 2017)